Related Experiment Video
Updated: Aug 18, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population
Tessa M Bosch1, Linda M Kjellberg, Anja Bouwers
1Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, 1066 EC Amsterdam, The Netherlands. aptbo@slz.nl
Background:
ABCG2 is a drug transporter involved in the protection of tissues by actively transporting toxic substances and xenobiotics out of cells. Cancer cells overexpressing the ABCG2 gene show multidrug resistance to mitoxantrone-, methotrexate-, doxorubicin-, and camptothecin-based anticancer drugs, such as topotecan and SN-38. Large interindividual differences have been shown in oral availability and clearance of drugs that are substrates for ABCG2. Variation in the ABCG2 gene, such as single nucleotide polymorphisms (SNPs), can possibly explain the variability in pharmacokinetics of ABCG2 substrates.
Aim:
This study was performed to screen for SNPs in the ABCG2 gene to determine the frequencies of currently known and previously unknown SNPs in a Dutch population.
Methods:
Blood samples were obtained from 100 healthy volunteers to isolate genomic DNA. PCR amplification was performed, followed by DNA sequencing. The population, of which the ethnicity was 93% Caucasian, consisted of 79 female individuals and 21 males.
Results:
In total, 19 SNPs were found in the ABCG2 gene, of which 7 were previously unknown. The SNPs G8883A in exon 5 and C44168T in exon 14 cause an amino acid change of R160Q and R575X, respectively. Most of the previously unknown SNPs were found in introns.
Conclusions:
The results will be used in future studies to explore the influence of the different SNPs on ABCG2 protein expression, activity, and substrate specificity. In addition, the results can be used to study the effects of genetic polymorphisms in the ABCG2 gene on the pharmacokinetic profile of anticancer drugs.
Insights
Researchers identified 19 single nucleotide polymorphisms (SNPs) in the ABCG2 gene within a Dutch population, including 7 novel variants. These ABCG2 gene variations may influence drug metabolism and efficacy, particularly for anticancer drugs.
Area of Science:
- Pharmacogenomics
- Molecular Biology
- Genetics
Background:
- The ATP-binding cassette transporter ABCG2 (also known as Breast Cancer Resistance Protein) plays a crucial role in cellular defense against xenobiotics.
- Overexpression of ABCG2 in cancer cells contributes to multidrug resistance (MDR) against various chemotherapy agents.
- Significant inter-individual variability exists in the pharmacokinetics of drugs transported by ABCG2, potentially linked to genetic variations.
Purpose of the Study:
- To systematically screen the ABCG2 gene for single nucleotide polymorphisms (SNPs) in a healthy Dutch population.
- To determine the allele frequencies of known and novel SNPs within the ABCG2 gene.
Main Methods:
- Genomic DNA was isolated from blood samples of 100 healthy Dutch volunteers (79% female, 21% male).
- Polymerase chain reaction (PCR) amplification followed by DNA sequencing was employed to identify SNPs.
- The study population was predominantly of Caucasian ethnicity (93%).
Main Results:
- A total of 19 SNPs were identified in the ABCG2 gene.
- Seven of the identified SNPs were previously unreported.
- Notable SNPs include G8883A (R160Q) in exon 5 and C44168T (R575X) in exon 14, both resulting in amino acid substitutions. Many novel SNPs were located in intronic regions.
Conclusions:
- The identified SNPs in the ABCG2 gene provide a basis for future investigations into their functional impact.
- Further research will explore how these genetic variations affect ABCG2 protein expression, activity, and substrate interactions.
- These findings can contribute to understanding the influence of ABCG2 genetic polymorphisms on the pharmacokinetics of anticancer drugs.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Single Nucleotide Polymorphisms-SNPs

